The Canadian Press: Newfoundland settles with 3 gynecologic oncologists

The Canadian Press: Williams says N.L. has reached deal that will keep doctors in province

e-Patients White Paper - how they can help us heal health care - Tom Ferguson and the e-patients scholars working group

e-Patients_White_Paper.pdf (application/pdf Object)

Clinical trials regulation -- how Canada compares -- Shuchman 179 (7): 635 -- Canadian Medical Association Journal

Clinical trials regulation -- how Canada compares -- Shuchman 179 (7): 635 -- Canadian Medical Association Journal

In Response: Markman - Neoadjuvant chemo for ovarian cancer: the debate reconsidered (discussion)

PowerSearch Document

full text (news source) What is the role of neoadjuvant chemo - areas of confusion in oncology

PowerSearch Document

"RECOMMENDATIONS

* Patients unable to tolerate aggressive cytoreductive surgery should undergo neoadjuvant chemotherapy first.

* Neoadjuvant chemotherapy should become a standard alternative approach to treating patients with stage IV ovarian cancer.

* Women with stage IIIC disease should be evaluated by a gynecologic oncologist to determine the likelihood of optimal cytoreducibility. If residual macroscopic disease would be expected with surgery alone, the patient should be offered the option of neoadjuvant chemotherapy."

Reference Guide

Therapeutic Agents Mentioned in This Article

Carboplatin

Cisplatin

Cyclophosphamide

Paclitaxel

free full text/abstract: Survival of HNPCC patients compared with sporadic colorectal cancer patients (Lynch Syndrome)

Abstract | Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients